Redeye: Xvivo Perfusion - Approaching Next Phase

Report this content

We foresee a continued high activity in the research portfolio in 2018, where the heart project, PrimECC and the liver project are expected to take another step forward in the development process.

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking.